Marked improvement of anti‑N‑methyl‑D‑aspartate receptor encephalitis by large‑dose methylprednisolone and plasmapheresis therapy combined with 18F‑fluorodeoxyglucose positron emission tomography imaging: A case report
- Authors:
- Bo Chen
- Yiqi Wang
- Yu Geng
- Yuehong Huang
- Shunyuan Guo
- Xiawa Mao
View Affiliations
Affiliations: Department of Neurology, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China, Department of Urology, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China
- Published online on: July 16, 2014 https://doi.org/10.3892/etm.2014.1849
-
Pages:
1167-1169
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Anti‑N‑methyl‑D‑aspartate receptor (anti‑NMDAR) encephalitis, a recently defined and frequently misdiagnosed disease characterized by psychiatric symptoms, seizures, movement disorders and autonomic dysfunction, has been observed predominantly in young females with ovarian teratoma. Conventional imaging techniques, including computed tomography (CT) and magnetic resonance imaging (MRI), are often ineffective for diagnosis of the disease. If diagnosed early, the initiation of immunotherapy and removal of the tumor (if present) may result in recovery. The current study presents the case of a 38‑year‑old female with classic clinical symptoms of anti‑NMDAR encephalitis. The MRI brain scan results were unremarkable, cerebral spinal fluid (CSF) biochemistry indicated non‑specific lymphocytic pleocytosis and the CSF microbiology studies were negative. 18F‑fluorodeoxyglucose positron emission tomography (18F‑FDG PET) imaging revealed significant generalized asymmetric hypometabolism. The patient demonstrated marked recovery following treatment with a high dose of corticosteroids and plasmapheresis. Accordingly, the follow‑up 18F‑FDG PET imaging revealed significant improvement.
View References
|
1
|
Dalmau J, Tüzün E, Wu HY, et al:
Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis
associated with ovarian teratoma. Ann Neurol. 61:25–36. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Graus F and Dalmau J: Paraneoplastic
neurological syndromes: diagnosis and treatment. Curr Opin Neurol.
20:732–737. 2007.PubMed/NCBI
|
|
3
|
Irani SR, Bera K, Waters P, et al:
N-methyl-D-aspartate antibody encephalitis: temporal progression of
clinical and paraclinical observations in a predominantly
non-paraneoplastic disorder of both sexes. Brain. 133:1655–1667.
2010. View Article : Google Scholar
|
|
4
|
Vincent A and Bien CG: Anti-NMDA-receptor
encephalitis: a cause of psychiatric, seizure, and movement
disorders in young adults. Lancet Neurol. 7:1074–1075. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Florance NR, Davis RL, Lam C, et al:
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children
and adolescents. Ann Neuro1. 66:11–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leypoldt F, Buchert R, Kleiter I, et al:
Fluorodeoxyglucose positron emission tomography in
anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern
of disease. J Neurol Neurosurg Psychiatry. 83:681–686. 2012.
View Article : Google Scholar
|
|
7
|
Greiner H, Leach JL, Lee KH and Krueger
DA: Anti-NMDA receptor encephalitis presenting with imaging
findings and clinical features mimicking Rasmussen syndrome.
Seizure. 20:266–270. 2011. View Article : Google Scholar
|
|
8
|
Maqbool M, Oleske DA, Huq AH, Salman BA,
Khodabakhsh K and Chugani HT: Novel FDG-PET findings in anti-NMDA
receptor encephalitis: a case based report. J Child Neurol.
26:1325–1328. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pillai SC, Gill D, Webster R, Howman-Giles
R and Dale RC: Cortical hypometabolism demonstrated by PET in
relapsing NMDA receptor encephalitis. Pediatr Neurol. 43:217–220.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Baumgartner A, Rauer S, Mader I and Meyer
PT: Cerebral FDG-PET and MRI findings in autoimmune limbic
encephalitis: correlation with autoantibody types. J Neurol.
260:2744–2753. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dalmau J, Lancaster E, Martinez-Hernandez
E, Rosenfeld MR and Balice-Gordon R: Clinical experience and
laboratory investigations in patients with anti-NMDAR encephalitis.
Lancet Neuro1. 10:63–74. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Titulaer MJ, McCracken L, Gabilondo I, et
al: Treatment and prognostic factors for long-term outcome in
patients with anti-NMDA receptor encephalitis: an observational
cohort study. Lancet Neurol. 12:157–165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pham HP, Daniel-Johnson JA, Stotler BA,
Stephens H and Schwartz J: Therapeutic plasma exchange for the
treatment of anti-NMDA receptor encephalitis. J Clin Apher.
26:320–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
